StartseitePodcastsThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug CompanyThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug Company20.11.2025 · 1 Std. 13 Min.Folge abspielenAb dieser Stelle teilenShownotesNeil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.Alle Folgen von The Long Run with Luke Timmerman